10バイアルパック在庫 622%オフCJC-1295 + Ipamorelin 5 mg + 5 mg
古典的 GHRH + グレリン模倣スタック
CJC-1295 and Ipamorelin research stack, Australian-shipped. Lab-verified to ≥99% purity.
研究用途専用。 本化合物は体外研究および実験室用途に限り販売され、人体への摂取や治療目的での使用を意図していません。ご購入をもって、適格な研究者であること、および当社の 免責事項全文に同意したものとみなします。
残り6パック
CJC-1295（GHRH アナログ）と選択的グレリン模倣薬 Ipamorelin を同一の研究用バイアルに組み合わせた製品。ペプチド研究で最も検討されてきた二重機序 GH 分泌促進スタックです。
CJC-1295 and Ipamorelin are a long-standing pair in growth-hormone secretagogue research. CJC-1295 is a 30-amino-acid analogue of growth-hormone-releasing hormone (GHRH); Ipamorelin is a selective ghrelin receptor agonist (a 'GHS' or growth-hormone secretagogue). The two compounds act on different receptors but converge on the somatotrophs of the anterior pituitary, where they amplify pulsatile growth-hormone release in pre-clinical models.
Quantum Labs supplies the pair as a pre-portioned research stack — two lyophilised vials shipped together, each HPLC-verified to ≥99% purity. Australian-shipped from local stock; supplied for laboratory research use only.
作用機序
CJC-1295 が基底の GHRH 受容体シグナルを支え、Ipamorelin が選択的グレリン受容体パルスを駆動します。研究では、研究対象において相乗的で生理的な GH 放出パターンが示唆されています。
純度規格 ≥99% に対して HPLC で検証。認定された第三者ラボが独立して試験しています。
CJC-1295: DAC vs no-DAC
CJC-1295 exists in two research forms: with Drug Affinity Complex (DAC) and without. The DAC variant binds albumin in plasma, extending the half-life from minutes to days. Research designs targeting acute pulsatile GH release typically use the no-DAC form (modified GRF 1-29); studies modelling sustained GH elevation use the DAC variant. Our supply is the no-DAC research-grade form unless otherwise specified.
CJC-1295 + Ipamorelin — よくある質問
What is the CJC-1295 + Ipamorelin stack?
It is a research pairing of two growth-hormone secretagogues: CJC-1295 (a GHRH analogue) and Ipamorelin (a selective ghrelin receptor agonist). The two compounds act on different receptors but converge on stimulating pulsatile growth-hormone release in pre-clinical models.
How does CJC-1295 differ from Ipamorelin?
CJC-1295 mimics growth-hormone-releasing hormone (GHRH), binding the GHRH receptor on pituitary somatotrophs. Ipamorelin mimics ghrelin, binding the growth-hormone secretagogue receptor (GHSR-1a). The two pathways are independent but synergistic — combining them produces a larger pulsatile GH response in research models than either compound alone.
Is CJC-1295 + Ipamorelin legal in Australia?
Both compounds are restricted for human therapeutic supply in Australia and remain available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies the stack for research use only.
What does selective mean for Ipamorelin?
Ipamorelin is described as a selective ghrelin agonist because it activates the GH-release pathway with minimal effect on cortisol, prolactin, or aldosterone — distinguishing it from earlier-generation GHS molecules. This selectivity has made it a preferred research tool for isolating GH-specific effects.
What is the typical CJC-1295 + Ipamorelin research dosage?
Published research protocols have used wide dose ranges depending on the model and species. Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.
Are CJC-1295 and Ipamorelin used together?
Yes — combined-administration research is common precisely because the two compounds act on independent receptors and produce a synergistic GH-release response. The combination is a standard tool in growth-hormone secretagogue research.
CJC-1295 + Ipamorelin に関連するガイド
研究者はこちらも閲覧しています
10バイアルパック18%オフTesamorelin
凍結乾燥粉末10 mg · 3 strengths
安定化 GHRH アナログ
1 件のスタックに収録
おすすめ10バイアルパック22%オフMelanotan II
凍結乾燥粉末10 mg
α-MSH アナログの研究用ペプチド